Welcome to

MST Financial

A research driven financial services platform.

MST has an absolute focus on value creation for our clients. MST's innovative platform enables the best talent in financial services to collaborate with clients in an exclusive partnership.

MST offers institutional research through its Marquee platform and issuer sponsored equity research through its Access platform.

Institutional Large Cap Research

Mid-Large Cap and Emerging Research

Issuer Sponsored. Open Access to Investors

Investment Solutions

MST Access Strategic Market Outlook Webinar

Sep 09, 2021

MST Financial is delighted to announce the MST Access Strategic Market Outlook webinar will be taking place on Tuesday, 14 September at 4.00pm (AEST).

Carina Biotech raises $5.4m to fund Phase I clinical trials

Aug 30, 2021

MST Financial is proud to have supported Carina Biotech with its $5.4 million pre-IPO equity raising, acting as Lead Manager to the offer.

MST Financial appointed Lead Manager for Kyckr Limited (KYK.ASX) equity raising

Aug 30, 2021

MST Financial is delighted to be appointed Lead Manager and Bookrunner for Kyckr's (KYK.ASX) $6 million equity raising.

Poseidon Nickel Limited (POS.ASX) announces $22 million equity raising

Aug 08, 2021

MST Financial is proud to have supported Poseidon Nickel Limited with its $22 million equity raising, acting as Co-Manager to the offer.

Cynata Therapeutics (CYP.ASX) is unlocking the potential of stem cells

Aug 05, 2021

MST Access Senior Research Analyst, Chris Kallos, CFA explores how Cynata Therapeutics (ASX:CYP) is unlocking the potential of stem cells in developing therapeutic products to treat serious disorders.

Pointsbet Holdings Ltd (PBH.ASX) raises $400m

Jul 29, 2021

MST Financial is delighted to act as Joint Lead Manager in supporting PointsBet with its $400 million equity raising.